BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Prognosis
48 results:

  • 1. Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell lung cancer.
    Rigamonti A; Viatore M; Polidori R; Rahal D; Erreni M; Fumagalli MR; Zanini D; Doni A; Putignano AR; Bossi P; Voulaz E; Alloisio M; Rossi S; Zucali PA; Santoro A; Balzano V; Nisticò P; Feuerhake F; Mantovani A; Locati M; Marchesi F
    Cancer Res; 2024 Apr; 84(7):1165-1177. PubMed ID: 38315789
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Peripheral arterial rather than venous blood is a better source of circulating tumor cells in early lung cancer.
    Wang ZD; Feng YF; Wang YS; Ma Y; Liu J; Li D; Li S; Zhang GD
    Thorac Cancer; 2024 Mar; 15(8):654-660. PubMed ID: 38297462
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.
    Ikemoto S; Sakurai F; Tokuoka S; Yamashita T; Takayama K; Hoshi K; Okabe T; Sumiyoshi I; Togo S; Takahashi K; Tachibana M; Mizuguchi H
    PLoS One; 2023; 18(10):e0286323. PubMed ID: 37856461
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature.
    Zhang P; Zhang X; Cui Y; Gong Z; Wang W; Lin S
    Front Immunol; 2023; 14():1244144. PubMed ID: 37671160
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation.
    Lin YS; Chiang SF; Chen CY; Hong WZ; Chen TW; Chen WT; Ke TW; Yang PC; Liang JA; Shiau AC; Chao KSC; Huang KC
    Cancer Immunol Immunother; 2023 Jul; 72(7):2283-2297. PubMed ID: 36881132
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma.
    Che TF; Chiu CH; Wu YC; Chen JY; Chou TY; Cheng YC; Chiang CL; Huang CS; Tuang IS; Ho YH; Hong JH; Huang YJ; Ho HL; Chang YC
    Lung Cancer; 2023 Apr; 178():198-205. PubMed ID: 36871344
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade.
    Mitsuhashi A; Koyama K; Ogino H; Afroj T; Nguyen NT; Yoneda H; Otsuka K; Sugimoto M; Kondoh O; Nokihara H; Hanibuchi M; Takizawa H; Shinohara T; Nishioka Y
    Cell Rep; 2023 Mar; 42(3):112162. PubMed ID: 36870329
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
    Karamitopoulou E; Wenning AS; Acharjee A; Zlobec I; Aeschbacher P; Perren A; Gloor B
    Gut; 2023 Aug; 72(8):1523-1533. PubMed ID: 36792355
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients.
    Yi B; Cheng Y; Chang R; Zhou W; Tang H; Gao Y; Zhang C
    Biosci Rep; 2023 Feb; 43(2):. PubMed ID: 36633963
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD20
    Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
    Front Immunol; 2022; 13():865596. PubMed ID: 35634306
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
    Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
    Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploration of genes and tumor infiltrating lymphocytes in female lung adenocarcinoma microenvironment that predicted prognosis.
    Wang L; Wang H; Wei S; Zhang Z
    Medicine (Baltimore); 2021 Dec; 100(51):e28215. PubMed ID: 34941080
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences.
    Fan T; Li C; He J
    Biol Sex Differ; 2021 Dec; 12(1):64. PubMed ID: 34863300
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
    Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
    Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
    [No Abstract]    [Full Text] [Related]  

  • 16. Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genes.
    Wu W; Jia L; Zhang Y; Zhao J; Dong Y; Qiang Y
    Bioengineered; 2021 Dec; 12(1):7417-7431. PubMed ID: 34612148
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TUSC8 enhances cisplatin sensitivity of NSCLC cells through regulating VEGFA.
    Shi N; Feng D; Gu Y; Zheng C; Miao M
    J BUON; 2021; 26(2):336-344. PubMed ID: 34076977
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
    Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circular RNA circ-PRKCI promotes lung cancer progression by binding to microRNA-1324 to regulate MECP2 expression.
    Meng Y; Sun WL; Wang M; Sun J
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10557-10565. PubMed ID: 33155212
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
    Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
    IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.